Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) (WARFARIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01305148
Recruitment Status : Suspended (Sponsor is raising funds for the remainder of the study)
First Posted : February 28, 2011
Last Update Posted : August 31, 2015
Information provided by (Responsible Party):
Iverson Genetic Diagnostics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 2015
Estimated Study Completion Date : December 2015